Olema Pharmaceuticals

Filed a patent for "methods of treating estrogen receptor-mediated disorders" on Thu, July 14, 2022

Filed a patent for "estrogen receptor modulators and uses thereof" on Fri, August 19, 2022

Filed a patent for "estrogen receptor modulators and uses thereof" on Fri, August 19, 2022

Filed a patent for "estrogen receptor modulators and uses thereof" on Fri, August 19, 2022

Filed a patent for "methods of treating estrogen receptor-mediated disorders" on Wed, October 5, 2022

Filed a patent for "methods of treating estrogen receptor-mediated disorders" on Wed, October 5, 2022

Filed a patent for "tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs" on Thu, April 25, 2024